Global Human Papilloma Virus Testing Market: Overview

Science states that all sexually active men and women will at some point in their life contract human papilloma virus. While there is no cure for the disease, most studies state that vaccination at the age of 11 or 12 will prevent the disease. However, with lack of awareness among people, the number of cases of HPV continue to rise in regions of the world. As a result, the need for diagnosis becomes imperative, thus driving growth in the global human papilloma virus testing market.

Over the years, the global market for human papilloma virus testing has grown at a steady pace, and a recent report by Transparency Market Research states that it will grow further in the coming years. The report also sheds light on the prevailing trends in the global human papilloma virus testing market, and also provides extensive details about the size, share, growth, and competitive dynamics.

Global Human Papilloma Virus Testing Market: Notable Developments

Some of the notable developments of the global human papilloma virus testing market are:

  • QIAGEN in September 2015 launched a test that aids diagnosis in women. Called the careHPV test and HC2 collection device, this is QIAGENs effort to detect cases of cancer at an early stage among women.
  • Few months before QIAGEN launched its test for HPV in women, Roche, in April 2014, came out with its test for diagnosing cervical cancer. The test was named cobas HPV hat received approval from the US FDA around this time.
  • In February 2014, BD Onclarity HPV Assay obtained CE/IVD marking. This opened doors of growth for the company.

Most players in the global human papilloma virus testing market are focusing on improving their existing products and making the process easier for use. At the same time, the cost of testing is also another aspect that most manufacturers are working on. As a result, companies have invested significantly on research and development in the last few years. Some of the prominent players in the global market for HPV testing are Abbott, bioMerieux, Biomedical Diagnostics, CanAG Diagnostics, Epigenomics, CeMines, Bio-Rad, Ipsogen, J&J Diagnostics, Fujirebio, Guided Therapeutics, Gen-Probe, Polartechnics, Qiagen, Radient Pharmaceuticals, Sequenom, Targeted Diagnostics & Therapeutics, OncoLab, Hologic, Roche, and Siemens Healthcare. 

Global Human Papilloma Virus Testing Market: Key Trends

Rising Cases of Cervical Cancer to Stoke Demand

World Health Organization (WHO) stated that cervical cancer is the fourth largest reason for death among women in the world today. In 2018 alone, 570,000 new cases were reported accounting to 6.6% of total cancer cases among women. This hints at a trend where the need of products in the global human papilloma virus testing market will grow in the coming years.

Awareness to Stimulate Consumption

While it is doctors who confirm diagnosis and prescribe treatment, patients themselves are well aware about the diseases and drugs. Ease access to information on the web, thanks to world-wide penetration of the internet and widespread use of smartphones. As a result, people realize the need to stay healthy and visit a doctor the moment they sense symptoms of a disease. All these aspects are expected to stimulate consumption in the global market for human papilloma virus testing.

Global Human Papilloma Virus Testing Market: Geographical Analysis

The United States is, perhaps, the most developed country when it comes to healthcare. To add to this, people are also aware about the consequences of diseases like cervical cancer. Hence, most women, above the age of 30, undergo an annual check-up. This way, they attempt to ensure that any disease, if detected, can be tended at early stages, preventing the need for painful treatment and loss of money. The rising women population in some countries of Asia Pacific will stem growth in the region. As a result, the demand for products in the global human papilloma virus testing market will improve in the future.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Human Papilloma Virus Testing Market

Pre Book